Works matching IS 17589193 AND DT 2025 AND VI 17 AND IP 1
Results: 53
Cornuside alleviates cognitive impairments induced by Aβ<sub>1−42</sub> through attenuating NLRP3-mediated neurotoxicity by promoting mitophagy.
- Published in:
- Alzheimer's Research & Therapy, 2025, v. 17, n. 1, p. 1, doi. 10.1186/s13195-025-01695-w
- By:
- Publication type:
- Article
The impact of kidney function on Alzheimer's disease blood biomarkers: implications for predicting amyloid-β positivity.
- Published in:
- Alzheimer's Research & Therapy, 2025, v. 17, n. 1, p. 1, doi. 10.1186/s13195-025-01692-z
- By:
- Publication type:
- Article
Social frailty and its association with cognitive trajectories in older adults: a prospective cohort study.
- Published in:
- Alzheimer's Research & Therapy, 2025, v. 17, n. 1, p. 1, doi. 10.1186/s13195-025-01687-w
- By:
- Publication type:
- Article
γ-Secretase modulator resistance of an aggressive Alzheimer-causing presenilin mutant can be overcome in the heterozygous patient state by a set of advanced compounds.
- Published in:
- Alzheimer's Research & Therapy, 2025, v. 17, n. 1, p. 1, doi. 10.1186/s13195-025-01680-3
- By:
- Publication type:
- Article
Sex differences in the association of Alzheimer's disease biomarkers and cognition in a multicenter memory clinic study.
- Published in:
- Alzheimer's Research & Therapy, 2025, v. 17, n. 1, p. 1, doi. 10.1186/s13195-025-01684-z
- By:
- Publication type:
- Article
Investigating the Aβ and tau pathology in autosomal dominant Alzheimer's disease: insights from hybrid PET/MRI and network mapping.
- Published in:
- Alzheimer's Research & Therapy, 2025, v. 17, n. 1, p. 1, doi. 10.1186/s13195-025-01690-1
- By:
- Publication type:
- Article
Circular RNA APP contributes to Alzheimer's disease pathogenesis by modulating microglial polarization via miR-1906/CLIC1 axis.
- Published in:
- Alzheimer's Research & Therapy, 2025, v. 17, n. 1, p. 1, doi. 10.1186/s13195-025-01698-7
- By:
- Publication type:
- Article
Pathway-based network medicine identifies novel natural products for Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2025, v. 17, n. 1, p. 1, doi. 10.1186/s13195-025-01694-x
- By:
- Publication type:
- Article
Plasma Hepcidin as a potential informative biomarker of Alzheimer disease and vascular dementia.
- Published in:
- Alzheimer's Research & Therapy, 2025, v. 17, n. 1, p. 1, doi. 10.1186/s13195-025-01696-9
- By:
- Publication type:
- Article
Prediction of cognitive conversion within the Alzheimer's disease continuum using deep learning.
- Published in:
- Alzheimer's Research & Therapy, 2025, v. 17, n. 1, p. 1, doi. 10.1186/s13195-025-01686-x
- By:
- Publication type:
- Article
Treatment of Alzheimer's Disease subjects with expanded non-genetically modified autologous natural killer cells (SNK01): a phase I study.
- Published in:
- Alzheimer's Research & Therapy, 2025, v. 17, n. 1, p. 1, doi. 10.1186/s13195-025-01681-2
- By:
- Publication type:
- Article
Treatment of Alzheimer's Disease subjects with expanded non-genetically modified autologous natural killer cells (SNK01): a phase I study.
- Published in:
- Alzheimer's Research & Therapy, 2025, v. 17, n. 1, p. 1, doi. 10.1186/s13195-025-01681-2
- By:
- Publication type:
- Article
β-synuclein in cerebrospinal fluid as a potential biomarker for distinguishing human prion diseases from Alzheimer's and Parkinson's disease.
- Published in:
- Alzheimer's Research & Therapy, 2025, v. 17, n. 1, p. 1, doi. 10.1186/s13195-025-01688-9
- By:
- Publication type:
- Article
Heterogeneous clinical phenotypes of sporadic early-onset Alzheimer's disease: a neuropsychological data-driven approach.
- Published in:
- Alzheimer's Research & Therapy, 2025, v. 17, n. 1, p. 1, doi. 10.1186/s13195-025-01689-8
- By:
- Publication type:
- Article
A systematic review and meta-analysis of the impact of transcranial direct current stimulation on cognitive function in older adults with cognitive impairments: the influence of dosage parameters.
- Published in:
- Alzheimer's Research & Therapy, 2025, v. 17, n. 1, p. 1, doi. 10.1186/s13195-025-01677-y
- By:
- Publication type:
- Article
Multi-omics analyses identify gut microbiota-fecal metabolites-brain-cognition pathways in the Alzheimer's disease continuum.
- Published in:
- Alzheimer's Research & Therapy, 2025, v. 17, n. 1, p. 1, doi. 10.1186/s13195-025-01683-0
- By:
- Publication type:
- Article
Delta-opioid receptor signaling alleviates neuropathology and cognitive impairment in the mouse model of Alzheimer's disease by regulating microglia homeostasis and inhibiting HMGB1 pathway.
- Published in:
- Alzheimer's Research & Therapy, 2025, v. 17, n. 1, p. 1, doi. 10.1186/s13195-025-01682-1
- By:
- Publication type:
- Article
Rotation errors in path integration are associated with Alzheimer's disease tau pathology: a cross-sectional study.
- Published in:
- Alzheimer's Research & Therapy, 2025, v. 17, n. 1, p. 1, doi. 10.1186/s13195-025-01679-w
- By:
- Publication type:
- Article
Retinal optical coherence tomography intensity spatial correlation features as new biomarkers for confirmed Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2025, v. 17, n. 1, p. 1, doi. 10.1186/s13195-025-01676-z
- By:
- Publication type:
- Article
Effects of intensive lifestyle changes on the progression of mild cognitive impairment or early dementia due to Alzheimer's disease: the need for rigor.
- Published in:
- Alzheimer's Research & Therapy, 2025, v. 17, n. 1, p. 1, doi. 10.1186/s13195-024-01621-6
- By:
- Publication type:
- Article
Glymphatic system clearance and Alzheimer's disease risk: a CSF proteome-wide study.
- Published in:
- Alzheimer's Research & Therapy, 2025, v. 17, n. 1, p. 1, doi. 10.1186/s13195-024-01612-7
- By:
- Publication type:
- Article
The ABC transporter A7 modulates neuroinflammation via NLRP3 inflammasome in Alzheimer’s disease mice.
- Published in:
- Alzheimer's Research & Therapy, 2025, v. 17, n. 1, p. 1, doi. 10.1186/s13195-025-01673-2
- By:
- Publication type:
- Article
Association of Alzheimer's and Lewy body disease pathology with basal forebrain volume and cognitive impairment.
- Published in:
- Alzheimer's Research & Therapy, 2025, v. 17, n. 1, p. 1, doi. 10.1186/s13195-025-01678-x
- By:
- Publication type:
- Article
RADAR-AD: assessment of multiple remote monitoring technologies for early detection of Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2025, v. 17, n. 1, p. 1, doi. 10.1186/s13195-025-01675-0
- By:
- Publication type:
- Article
Exploring sex differences in Alzheimer's disease: a comprehensive analysis of a large patient cohort from a memory unit.
- Published in:
- Alzheimer's Research & Therapy, 2025, v. 17, n. 1, p. 1, doi. 10.1186/s13195-024-01656-9
- By:
- Publication type:
- Article
Exome sequencing reveals a rare damaging variant in GRIN2C in familial late-onset Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2025, v. 17, n. 1, p. 1, doi. 10.1186/s13195-024-01661-y
- By:
- Publication type:
- Article
CEST imaging combined with <sup>1</sup>H-MRS reveal the neuroprotective effects of riluzole by improving neurotransmitter imbalances in Alzheimer's disease mice.
- Published in:
- Alzheimer's Research & Therapy, 2025, v. 17, n. 1, p. 1, doi. 10.1186/s13195-025-01672-3
- By:
- Publication type:
- Article
Targeting early tau pathology: probiotic diet enhances cognitive function and reduces inflammation in a preclinical Alzheimer's model.
- Published in:
- Alzheimer's Research & Therapy, 2025, v. 17, n. 1, p. 1, doi. 10.1186/s13195-025-01674-1
- By:
- Publication type:
- Article
Effectiveness and utilization of a cognitive screening program for primary geriatric care.
- Published in:
- Alzheimer's Research & Therapy, 2025, v. 17, n. 1, p. 1, doi. 10.1186/s13195-024-01637-y
- By:
- Publication type:
- Article
Timing of risk factors, prodromal features, and comorbidities of dementia from a large health claims case–control study.
- Published in:
- Alzheimer's Research & Therapy, 2025, v. 17, n. 1, p. 1, doi. 10.1186/s13195-024-01662-x
- By:
- Publication type:
- Article
Short-term variability of Alzheimer's disease plasma biomarkers in a mixed memory clinic cohort.
- Published in:
- Alzheimer's Research & Therapy, 2025, v. 17, n. 1, p. 1, doi. 10.1186/s13195-024-01658-7
- By:
- Publication type:
- Article
Machine learning models for dementia screening to classify brain amyloid positivity on positron emission tomography using blood markers and demographic characteristics: a retrospective observational study.
- Published in:
- Alzheimer's Research & Therapy, 2025, v. 17, n. 1, p. 1, doi. 10.1186/s13195-024-01650-1
- By:
- Publication type:
- Article
Association of antihypertensive drug target genes with alzheimer's disease: a mendelian randomization study.
- Published in:
- Alzheimer's Research & Therapy, 2025, v. 17, n. 1, p. 1, doi. 10.1186/s13195-025-01671-4
- By:
- Publication type:
- Article
Variables associated with cognitive function: an exposome-wide and mendelian randomization analysis.
- Published in:
- Alzheimer's Research & Therapy, 2025, v. 17, n. 1, p. 1, doi. 10.1186/s13195-025-01670-5
- By:
- Publication type:
- Article
Brain iron deposition and cognitive decline in patients with cerebral small vessel disease : a quantitative susceptibility mapping study.
- Published in:
- Alzheimer's Research & Therapy, 2025, v. 17, n. 1, p. 1, doi. 10.1186/s13195-024-01638-x
- By:
- Publication type:
- Article
Neuropathological contributions to grey matter atrophy and white matter hyperintensities in amnestic dementia.
- Published in:
- Alzheimer's Research & Therapy, 2025, v. 17, n. 1, p. 1, doi. 10.1186/s13195-024-01633-2
- By:
- Publication type:
- Article
Post-marketing safety concerns with lecanemab: a pharmacovigilance study based on the FDA Adverse Event Reporting System database.
- Published in:
- Alzheimer's Research & Therapy, 2025, v. 17, n. 1, p. 1, doi. 10.1186/s13195-024-01669-4
- By:
- Publication type:
- Article
evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2025, v. 17, n. 1, p. 1, doi. 10.1186/s13195-024-01666-7
- By:
- Publication type:
- Article
Association and multimodal model of retinal and blood-based biomarkers for detection of preclinical Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2025, v. 17, n. 1, p. 1, doi. 10.1186/s13195-024-01668-5
- By:
- Publication type:
- Article
Neuronal CD59 isoforms IRIS-1 and IRIS-2 as regulators of neurotransmitter release with implications for Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2025, v. 17, n. 1, p. 1, doi. 10.1186/s13195-024-01660-z
- By:
- Publication type:
- Article
Uncovering the epigenetic regulatory clues of PRRT1 in Alzheimer's disease: a strategy integrating multi-omics analysis with explainable machine learning.
- Published in:
- Alzheimer's Research & Therapy, 2025, v. 17, n. 1, p. 1, doi. 10.1186/s13195-024-01646-x
- By:
- Publication type:
- Article
Subjective cognitive decline predicts longitudinal neuropsychological test performance in an unsupervised online setting in the Brain Health Registry.
- Published in:
- Alzheimer's Research & Therapy, 2025, v. 17, n. 1, p. 1, doi. 10.1186/s13195-024-01641-2
- By:
- Publication type:
- Article
Benchmarking Alzheimer's disease prediction: personalised risk assessment using polygenic risk scores across various methodologies and genome-wide studies.
- Published in:
- Alzheimer's Research & Therapy, 2025, v. 17, n. 1, p. 1, doi. 10.1186/s13195-024-01664-9
- By:
- Publication type:
- Article
Integrative multiomics reveals common endotypes across PSEN1, PSEN2, and APP mutations in familial Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2025, v. 17, n. 1, p. 1, doi. 10.1186/s13195-024-01659-6
- By:
- Publication type:
- Article
Integrative multiomics reveals common endotypes across PSEN1, PSEN2, and APP mutations in familial Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2025, v. 17, n. 1, p. 1, doi. 10.1186/s13195-024-01659-6
- By:
- Publication type:
- Article
The cerebral blood flow response to neuroactivation is reduced in cognitively normal men with β-amyloid accumulation.
- Published in:
- Alzheimer's Research & Therapy, 2025, v. 17, n. 1, p. 1, doi. 10.1186/s13195-024-01652-z
- By:
- Publication type:
- Article
Transcriptomic predictors of rapid progression from mild cognitive impairment to Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2025, v. 17, n. 1, p. 1, doi. 10.1186/s13195-024-01651-0
- By:
- Publication type:
- Article
Cerebrospinal fluid β2-microglobulin promotes the tau pathology through microglia–astrocyte communication in Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2025, v. 17, n. 1, p. 1, doi. 10.1186/s13195-024-01665-8
- By:
- Publication type:
- Article
Plasma phospho-tau217 as a predictive biomarker for Alzheimer's disease in a large south American cohort.
- Published in:
- Alzheimer's Research & Therapy, 2025, v. 17, n. 1, p. 1, doi. 10.1186/s13195-024-01655-w
- By:
- Publication type:
- Article
Benchmarking Alzheimer's disease prediction: personalised risk assessment using polygenic risk scores across various methodologies and genome-wide studies.
- Published in:
- Alzheimer's Research & Therapy, 2025, v. 17, n. 1, p. 1, doi. 10.1186/s13195-024-01664-9
- By:
- Publication type:
- Article